Autoimmune progesterone dermatitis (AIPD) triggered by intrauterine device (IUD): case report

Carvalho, Ana Luiza Ribeiro Bard de; Levy, Soloni Afra Pires; França, Alfeu Tavares; Tórtora, Rosângela Prendin; Fonseca, Juliana Salvini Barbosa Martins da; Blanc, Elisabete Da Silva; Lupi, Omar

doi:10.1186/1939-4551-8-s1-a106

Cited by 3 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One hundred twelve articles were found to include a case report meeting our inclusion criteria 3–114 . Within these articles, 132 unique cases of AIPD were identified.…”

Section: Resultsmentioning

confidence: 99%

“…Prior exposure was unclear or not reported in 31 cases (23.5%). Of those with prior exposure to exogenous progesterone, 52 patients did so through oral contraceptive pills, 4 patients through intrauterine devices, 65,101,106,110 3 patients through injectables, 3,49,54 1 through topical progesterone acetate, 5 and 1 through a vaginal progesterone suppository 78 . The method of exogenous progesterone exposure was not specified in 8 cases 3,10,34,42,44,63,113 …”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Autoimmune Progesterone Dermatitis: A Systematic Review

et al. 2021

View full text Add to dashboard Cite

Autoimmune progesterone dermatitis (AIPD) is a cyclical, cutaneous reaction to endogenous progesterone that occurs throughout the menstrual cycle. The cutaneous manifestations of AIPD vary greatly from patient to patient, ranging anywhere from urticaria to erythema multiforme to anaphylaxis. As such, recognition, diagnosis, and management of this condition are difficult for clinicians. In the present article, we conducted a systematic review of 112 articles and 132 individual cases to summarize the clinical features and presentation of AIPD while also summarizing the successes and failures of different treatment plans. Despite the great variety in clinical presentations, it is clear from the data that ovulation-suppressing medical therapies and surgery have the greatest success in treating AIPD, whereas more commonly used therapies such as antihistamines and systemic corticosteroids frequently fail in providing any relief. Further research is necessary to determine the exact pathogenesis of AIPD and allow for more targeted treatment.

show abstract

“…One hundred twelve articles were found to include a case report meeting our inclusion criteria 3–114 . Within these articles, 132 unique cases of AIPD were identified.…”

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Autoimmune Progesterone Dermatitis: A Systematic Review

et al. 2021

View full text Add to dashboard Cite

show abstract

Progesterone

2019

Reactions Weekly

View full text Add to dashboard Cite

A Case of Autoimmune progesterone dermatitis post-intrauterine device placement in rural occupied Palestine

Alheeh,

Shalalfeh,

Wajeeh

et al. 2024

SAGE Open Medical Case Reports

View full text Add to dashboard Cite

Autoimmune progesterone dermatitis is considered a rare cyclical autoimmune reaction to endogenous progesterone in fertile females that is characterized by skin lesions ranging from mild urticaria to anaphylaxis. A 30-year-old woman who had an intrauterine device placed, presented to her family medicine clinic with erythema and some edematous lesions, and pruritus. The skin biopsy showed perivascular infiltrate with neutrophils and was diagnosed as autoimmune progesterone dermatitis. Treatment included intrauterine device removal and treatment with tamoxifen. This is the first documented case of autoimmune progesterone dermatitis in occupied Palestine.

show abstract

Autoimmune progesterone dermatitis (AIPD) triggered by intrauterine device (IUD): case report

Cited by 3 publications

References 0 publications

Autoimmune Progesterone Dermatitis: A Systematic Review

Autoimmune Progesterone Dermatitis: A Systematic Review

Progesterone

A Case of Autoimmune progesterone dermatitis post-intrauterine device placement in rural occupied Palestine

Contact Info

Product

Resources

About